Grace M, Costello J, Colosia A, Wolowacz S, Ghaswalla P, Panozzo CA, Moore P. Economic and HRQoL burden in adults with RSV: a systematic literature review. Poster presented at the Communicable Diseases & Immunisation Conference 2023; June 20, 2023. Perth, Australia. Previously presented at the 2023 Respiratory Synctial Virus Foundation (RSVVW).
Katzmann JL, Laufs U, Diamand F, Wolowacz S, Becker C, Bilitou A. Addition of bempedoic acid to the lipid-lowering treatment pathway for high and very high-risk patients in Germany: a simulation study using the SANTORINI observational study cohort. Poster presented at the DGK 89th Annual Meeting; April 13, 2023. Mannheim, Germany.
Grace M, Costello J, Colosia A, Wolowacz S, Panozzo CA, Ghaswalla P. Economic and health-related quality of life burden in adults with RSV: a systematic literature review and gap analysis. Poster presented at the 2023 Respiratory Synctial Virus Foundation (RSVVW); February 22, 2023. Lisbon, Portugal.
Herring WL, Gould IG, Wittrup-Jensen V, Kuti E, Mettam S, Ertle J, Wolowacz S. A conceptual model for the economic evaluation of emerging nonalcoholic steatohepatitis therapies: the impact of treatment efficacy profiles on health outcomes. Poster presented at the 2020 SMDM 18th Biennial European Conference (Conference cancelled); June 16, 2020.
Masaquel C, Rothwell B, Bhaila R, Copley-Merriman C, Wolowacz S, Aguiar-Ibanez R, Patel N, Liu FX. A systematic review of utility estimates in melanoma in the adjuvant setting. Poster presented at the 2018 ISPOR 21st Annual European Congress; November 13, 2018. Barcelona, Spain.
Brockbank J, Wolowacz S. Economic evaluations of new oral anticoagulants for the prevention of venous thromboembolism after total hip or total knee replacement. Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.
Pearson IV, Hawe E, Zuluaga S, Scuito S, Wolowacz S, Haiderali A. Cost-effectiveness of ofatumumab plus chlorambucil in first-line chronic lymphocytic leukemia in the United Kingdom. Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.
Wolowacz SE, Hawe E, Pearson IV. Use of external data to guide long-term survival extrapolations of trial data for chronic lymphocytic leukemia. Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam.
Kontoudis I, Harries M, Mohr P, Grange F, Ehness R, Benjamin L, Siakpere O, Barth J, Stapelkamp C, Pfersch S, McLeod LD, Kaye JA, Wolowacz SE. Economic burden of melanoma in three European countries: a retrospective observational study. Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam, The Netherlands.
Rosseli D, Rueda J, Wolowacz SE, Brockbank JA, Abeysinghe SS. Cost-effectiveness of dabigatran compared with warfarin, apixaban, rivaroxaban and low molecular weight heparins for the treatment and secondary prevention of venous thromboembolism in Colombia. Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam, The Netherlands.
Purser MF, Mladsi DM, Wolowacz SE. A review of NICE technology appraisals using single-arm trials. Poster presented at the 2014 ISPOR 19th Annual International Meeting; June 3, 2014. Montreal, Canada.
Wolowacz S. The United Kingdom's national institute for health and clinical excellence: new developments. Poster presented at the 2009 ISPOR 12th Annual European Congress; November 19, 2009.
Wolowacz S, Jhaveri M, Tangirala K. Cost-utility model to evaluate adjuvant chemotherapy for early breast cancer in the United States. Poster presented at the 2009 ISPOR 12th Annual European Congress; October 28, 2009.
Bradley-Kennedy C, Wolowacz SE, Roskell NS. Cost-effectiveness of dabigatran etexilate in Canada for the primary prevention of venous thromboembolism in patients undergoing total knee or total hip replacement surgery. Poster presented at the International Society on Thrombosis and Haemostasis 22nd International Congress; July 11, 2009. Boston, MA.
Wolowacz SE, Roskell NS, Plumb JM, Clemens A, Robinson PA, Dolan G, Brenkel IJ. Cost-effectiveness of dabigatran etexilate 150 MG for the prevention of venous thromboembolism in elderly patients undergoing total hip or knee arthroplasty. Poster presented at the 2009 ISPOR 14th Annual International Meeting; May 16, 2009. Orlando, FL.
Javitt JC, Wolowacz SE, Roskell NS, Maciver F, Pleil A, Zlateva G. Balancing visual acuity benefits with systemic adverse effects in anti-VEGF therapy. Poster presented at the ARVO 9th Annual Meeting; May 2007; May 2007. Fort Lauderdale, FL.
Wolowacz SE. Economic analysis of macugen for age-related macular degeneration. Poster presented at the Royal College of Surgeons; February 2, 2007. London, England.
Wolowacz SE. The National Institute for Health and Clinical Excellence (NICE) Single Technology Appraisal (STA) process: an update on the first round of submissions. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 31, 2006.
Sculpher M, Longson C, Wolowacz SE, Khan S. The new National Institute of Health And Clinical Excellence (NICE) Single Technology Appraisal (STA) process: experience from the first round of completed appraisals. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 28, 2006. Copenhagen, Denmark.
Sculpher M, Longson C, Wolowacz SE, Khan S. The new National Institute of Health And Clinical Excellence (NICE) Single Technology Appraisal (STA) process: experience from the first round of submissions. Poster presented at the 2006 ISPOR 11th Annual International Meeting; May 2006. Philadelphia, PA.
Wolowacz SE, Roskell NS, Christie A, Kerr G, Cameron D. The cost of hospital care for relapsed breast cancer in the UK based on a large patient-level resource utilisation dataset. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 10, 2005. Florence, Italy.
Gaffney L, Sherrill EH, Wolowacz SE, Allen R, Connolly M. Predictors of health-related quality of life (HRQoL) in US patients suffering from rls. Poster presented at the International Congress on Parkinson's Disease and Movement Disorders; 2005.
Gaffney L, Sherrill B, Wolowacz SE, Allen R, Connolly M, Kirsch J. Evaluating the predictors of health-related quality of life in European respondents with restless legs syndrome. Poster presented at the ICPD meeting; 2005; 2005. Berlin, Germany.
Nicholls TJ, Carpenter BG, Rogers DJ, Cook DJ, Wolowacz SE, Smart JD. An investigationn of lectin binding sites on unfixed corneal and conjunctival surfaces of rats. Poster presented at the Proceedings of IinterLec; 2004.
McTaggart S, Anderson M, Wolowacz SE. Development of a tissue engineered ligament replacement. Poster presented at the 5th World Biomaterials Congress; 1996. Toronto, Canada.
Nicholls TJ, Cook JD, Rogers DJ, Wolowacz SE, Smart JD. The effect of exposure time and washing on the binding of two lectins to tissues from the precorneal region of rats. Poster presented at the British Pharmaceutical Society; 1994.
Wolowacz SE, Hamid O, Jones D, Lazare R. Ocular bioavailability of topical triamterene in the conscious rabbit by a non-invasive method. Poster presented at the British Toxicology Society meeting; April 1992. York, United Kingdom.
Wolowacz SE, Yon Hin BFY, Lowe CR. Covalent electropolymerisation of glucose oxidase in polypyrrole. Poster presented at the 3rd International Conference of Chemical Sensors; 1990. Cleveland, OH.